Kumquat Biosciences Inc.
Clinical trials sponsored by Kumquat Biosciences Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New pill targets hard-to-treat cancers with KRAS mutation Results expected Sep 2026 (estimated)
- New hope for advanced cancer: KQB198 trial launches Results expected Dec 2026 (estimated)
- New pill KQB198 tested for tough blood cancers Results expected Mar 2027 (estimated)